X
    學術可視化工作室RC   登錄   提交文稿
學術英文編修

Asian Journal of Pharmaceutical Sciences

期刊標題檢索 ASIAN J PHARM S 最新評論: How is the current situation? (2024-10-30)


期刊名稱:   ISSN:   主題領域:   影響因子範圍: -
索引:   類別:   開放訪問:   排序方式:

[Asian Journal of Pharmaceutical Sciences]您好,您是該頁面的第 56479 位訪客。

期刊簡介
期刊名稱Asian Journal of Pharmaceutical Sciences Asian Journal of Pharmaceutical Sciences
LetPub Score
6.8
52 ratings
Rate

Reputation
7.9

Influence
6.0

Speed
6.6

期刊簡稱ASIAN J PHARM SCI
ISSN1818-0876
E-ISSN2221-285X
h-index27
CiteScore
CiteScoreSJRSNIPCiteScore Rank
18.301.6621.573
Subject fieldQuartilesRankPercentile
Category: Pharmacology, Toxicology and Pharmaceutics
Subcategory: Pharmaceutical Science
Q14 / 183
Category: Pharmacology, Toxicology and Pharmaceutics
Subcategory: Pharmacology
Q110 / 313

自引率 (2023-2024)4.70%自引率趨勢
掲載範囲
Asian Journal of Pharmaceutical Sciences (AJPS) is the official journal of Asian Federation for Pharmaceutical Sciences (AFPS) and is indexed by Science Citation Index Expanded (SCIE). It provides the forum for reporting innovations, production methods, technologies, initiatives and the application of scientific knowledge to all aspects of pharmaceutics, including controlled drug release systems, drug targeting, physical pharmacy, pharmacodynamics, pharmacokinetics, pharmacogenomics, biopharmaceutics, drug and prodrug design, pharmaceutical analysis, drug stability, quality control, pharmaceutical engineering and material sciences.
官方網站http://www.journals.elsevier.com/asian-journal-of-pharmaceutical-sciences/
在線稿件提交https://www.editorialmanager.com/AJOPS
開放訪問Yes
出版商Shenyang Pharmaceutical University
主題領域Pharmacology, Toxicology and Pharmaceutics
出版國/地區China
發行頻率
創刊年0
每年文章數58每年文章數趨勢
黃金OA百分比95.51%
OA Related Info
APC: No
APC waiver:Check Notes
Other charges: No
Keywords: drug release systems、drug targeting、physical pharmacy、pharmacodynamics、pharmacokinetics、pharmacogenomics
Useful LinksAims & ScopeAuthor InstructionsEditorial BoardAnonymous peer review
Web of Science 四分位
2023-2024
WOS Quartile: Q1

CategoryEditionJIF QuartileJIF RankingJIF Percentage
PHARMACOLOGY & PHARMACYSCIEQ111/354
索引 (SCI or SCIE)Science Citation Index Expanded
鏈接到PubMed Central (PMC)https://www.ncbi.nlm.nih.gov/nlmcatalog?term=1818-0876%5BISSN%5D
平均審稿時間 *來自出版商的數據:
來自作者的數據: 17 Weeks
競爭力 *來自作者的數據:
參考鏈接
相關期刊 【Asian Journal of Pharmaceutical Sciences】CiteScore趨勢
自引率趨勢 每年文章數趨勢
作者評論
*所有的審稿過程指標,如接受率和審稿速度,僅限於用戶提交的稿件。因此,這些指標可能無法準確反映期刊的競爭力或速度。
  • 同一學科的期刊
  • CiteScore趨勢
  • 自引率趨勢
  • 每年文章數趨勢
  •  
    學科內的可信期刊 影響因子
    Bioengineering & Translational MedicineH-index: 0

    CiteScore: 8.40
    Journal of Pharmaceutical InvestigationH-index: 0

    CiteScore: 10.20
    PharmaceuticsH-index: 32

    CiteScore: 7.90
    Cancer NanotechnologyH-index: 0

    CiteScore: 5.20
    PharmaceuticalsH-index: 0

    CiteScore: 6.10
    Advanced TherapeuticsH-index: 0

    CiteScore: 7.10
    SCIENTIA PHARMACEUTICAH-index: 0

    CiteScore: 4.60
    BioImpactsH-index: 0

    CiteScore: 4.80
    Drug Metabolism LettersH-index: 0

    CiteScore: 2.80
    Recent Patents on Drug Delivery and FormulationH-index: 0

    CiteScore: 2.30
    學科內最受檢索的期刊 頁面查看次數
    Pharmaceutics120129
    Pharmaceuticals62875
    Bioengineering & Translational Medicine33082
    Advanced Therapeutics26124
    Cancer Nanotechnology12769
    BioImpacts6997
    International Journal of Pharmaceutics: X3318
    Journal of Pharmaceutical Investigation3270
    Recent Patents on Drug Delivery and Formulation2827
    Drug Metabolism Letters2696
  •  

    Asian Journal of Pharmaceutical Sciences Asian Journal of Pharmaceutical Sciences
    明年預測:
    穩步上升 無變化 逐步下降  刷新
  •  

     
  •  

     


首頁    上一頁    1    2    下一頁    末頁  (頁
/2)
  [Asian Journal of Pharmaceutical Sciences] 的評論撰寫評論
作者: lysole


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-10-30 15:47:00 評論於
How is the current situation?
(0) 讚! | lysole

作者: Qiyue Wang


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-09-14 09:12:14 評論於
The publication volume is not large, the speed is too slow, and it takes a month to submit a manuscript, which is still in the "with editor" status. The quality of the articles is average, but it is not easy to be accepted.
(0) 讚! | Qiyue Wang

作者: 半π


領域: 医学
審稿時間: 10.0 month(s)
結果: 拒稿


撰寫評論

2024-05-22 17:34:38 評論於
How to support it, submit more articles to make it huge
(0) 讚! | 半π

作者: 半π


領域: 医学
審稿時間: 10.0 month(s)
結果: 拒稿


撰寫評論

2024-05-22 17:33:44 評論於
Do you know any big shots?
(0) 讚! | 半π

作者: 半π


領域: 医学
審稿時間: 10.0 month(s)
結果: 拒稿


撰寫評論

2024-05-22 17:32:47 評論於
Why are these "operation distorted" journals so popular?
(0) 讚! | 半π

作者: YJ Zhu


領域: 医学
審稿時間: 6.0 month(s)
結果: 修改後接受


撰寫評論

2024-03-09 15:32:54 評論於
Received after about 1 year, but it was during the epidemic period so I don't know if it will be faster now. The reviewers' opinions are very professional, but the editing process is a bit slow. Overall, they are still quite responsible and communication is fast. It is said that without a strong background, it is difficult to get accepted, but my paper was rejected by JCR reviewers because I couldn't conduct experiments due to the epidemic. However, there is still a risk for urgent graduation, but the time is mainly spent on revisions 1 and 2, and the publication after acceptance is very fast and there is no page fee. The cost-effectiveness is still very high
(0) 讚! | YJ Zhu

作者: firsk


領域: 生物学
審稿時間: 12.0 month(s)
結果: 拒稿


撰寫評論

2024-02-27 10:46:15 評論於
I deeply regret not listening to the messages left by senior colleagues at letpub. The whole process has been dragging on for nearly a year (the time given on the Elsevier official website a year ago was normal, but has been updated recently, and the official website has also certified the outrageous review time). In the meantime, I have urged many times through various channels such as Elsevier, but the editors have been very irresponsible and casual in terms of inviting reviewers, processing speed, review duration control, revision time, etc., and ultimately rejected the paper. The whole process feels like amateur work, like a small workshop.

The acceptance rate given on the official website is only 4%, which should be deliberately suppressing the number of publications to increase the impact factor. This year, it has also been upgraded to Zone 1 of the Chinese Academy of Sciences, and the quality of the articles is uneven (I remember seeing articles reviewed in just a few days), so it is recommended to stay away if you do not have a strong background.

(I have been rejected for a long time, not just because of rejection, the above remarks are all very objective, there are many details and information in the middle that are inconvenient to explain in detail for fear of being discovered, so I can only sincerely advise you to listen! Stay away!!!
(15) 讚! | firsk

作者: 半π


領域: 医学
審稿時間: 10.0 month(s)
結果: 拒稿


撰寫評論

2023-12-14 20:29:36 評論於
Very ominous Stay away!
(0) 讚! | 半π

作者: luyue


領域:
審稿時間: 0.0 month(s)
結果: 拒稿


撰寫評論

2023-08-28 10:03:21 評論於
..
(0) 讚! | luyue

作者: 是俊风吖


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2023-06-24 19:58:57 評論於
Research focus: Pharmacology; Sharing of drug experiences: For those who have submitted manuscripts, when will we receive the manuscript number? This journal does not automatically generate it after submission
(0) 讚! | 是俊风吖

作者: 面面


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2023-05-19 17:41:21 評論於
Do you need the original data?
(0) 讚! | 面面

作者: 吐纳听双


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2023-03-29 11:32:19 評論於
How fast is the review speed?
(0) 讚! | 吐纳听双

作者: Daljon


領域: 生物学
審稿時間: 1.0 month(s)
結果: 修改後接受


撰寫評論

2023-03-21 19:30:32 評論於
Already received, the speed of review is acceptable.
(0) 讚! | Daljon

作者: Lily


領域: 材料科学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2022-12-26 13:09:13 評論於
Is there any news currently? Did the original poster win?
(0) 讚! | Lily

作者: Daljon


領域: 生物学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2022-12-10 09:48:36 評論於
The editing processing speed is still relatively fast.
(2) 讚! | Daljon

作者: Joyce Gunter


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2022-11-28 11:04:25 評論於
Have you voted?
(0) 讚! | Joyce Gunter

作者: +和+


領域: 医学
審稿時間: 2.0 month(s)
結果: 拒稿


撰寫評論

2022-10-22 01:27:53 評論於
I'm even more miserable than you. I had to go through two rounds of minor revisions during the first review, and the editor only provided minor revisions. They only gave me 15 days to make the modifications. After I carefully made the changes and sent it back, they unexpectedly rejected it. I'm so frustrated. Then I appealed (appealed for 2 months), but there hasn't been any news at all... Sigh...
(0) 讚! | +和+

作者: 云来涵育


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2022-07-19 08:02:32 評論於
Focused research area: Sharing of drug experiences: Can Traditional Chinese Medicine monomers be invested in?
(0) 讚! | 云来涵育

作者: longge99


領域: 医学
審稿時間: 5.0 month(s)
結果: 拒稿


撰寫評論

2022-01-19 11:10:03 評論於
Afraid of being doxxed, there will be a slight adjustment in the specific timing.
(0) 讚! | longge99

作者: longge99


領域: 医学
審稿時間: 5.0 month(s)
結果: 拒稿


撰寫評論

2022-01-19 11:08:37 評論於
Personal experience, not recommended for everyone to invest.
8.20 Control release - recommended to submit to this journal, accept transfer submission.
8.23 Modified and revised according to magazine requirements.
11.14 Urged for submission.
11.18 Received feedback, suggesting modifications (personally understood as minor revisions); no experiments need to be added and given a short time!
11.23 Revised.
1.15 Rejected, the editor-in-chief believed it lacked innovation.
1.17 Appeal.
No explanation has been received to date.

A complete waste of 5 months, 5 months, 5 months.

PS: During the process, the handling editor of the article appeared as AJPS guest editor in numbers.

Personally, I do not recommend it, purely a waste of time.
(82) 讚! | longge99

作者: 维尔娜菲茨杰拉德


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2021-12-30 08:13:23 評論於
ORCID is the acronym for Open Researcher and Contributor ID, and it is a open, non-profit organization. The ORCID ID is an unique and persistent academic identity for authors, which helps to differentiate authors from other researchers and also keeps track of all their research activities.

研究者可免费在https://orcid.org/signin注册ORCID ID,填写自己的姓名邮箱以及设置密码即可
(0) 讚! | 维尔娜菲茨杰拉德

作者: 上清雨真


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2021-12-27 15:26:09 評論於
What is ORCIDID? How to register?
(0) 讚! | 上清雨真

作者: 小孟们


領域: 医学
審稿時間: 4.0 month(s)
結果: 待定&不明


撰寫評論

2021-11-15 02:10:54 評論於
How is it now? Have you been hired?
(0) 讚! | 小孟们

作者: longge99


領域: 医学
審稿時間: 4.0 month(s)
結果: 待定&不明


撰寫評論

2021-08-23 10:17:03 評論於
Feeling a bit slow.
(22) 讚! | longge99

作者: 法慧和同


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2021-08-02 20:35:00 評論於
Great comments, you need to log in to view
(0) 讚! | 法慧和同

首頁    上一頁    1    2    下一頁    末頁  (頁
/2)

開始撰寫 [Asian Journal of Pharmaceutical Sciences] 的評論:





Contact us

Contact us  

Your name*

Your email*

Your message*

Please fill in all fields and provide a valid email.

Security Code*